Select a community
All Communities
Home > Community Treatment Reports > Carbidopa-Levodopa CR Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Carbidopa-Levodopa CR Treatment Report

Brand Names: Sinemet CR, Half Sinemet CR, Syndopa CR, Carbilev, Apo-Levocarb CR
Generic Name: Carbidopa-Levodopa CR

What is Carbidopa-Levodopa CR? A controlled release preparation of carbidopa/levodopa formulated to release a lower, smoother dose of medication. It is sometimes taken last thing at night in order to maintain dopamine levels throughout sleep and into the morning.

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

344 patients in the community are taking or have taken Carbidopa-Levodopa CR.

Top 10 (Show all)

Reason # Patients Percentage of patients
Treat Parkinson's 212 61%
Stiffness/Spasticity 14 4%
Other 14 4%
Restless Legs Syndrome (RLS) 4 1%
Mobility 3 <1%
Slowness 3 <1%
Support another treatment 3 <1%
Treat Parkinson,s 3 <1%
Parkinson's Disease 2 <1%
Mobility 2 <1%

Other treatments patients are taking for Treat Parkinson's include Carbidopa-Levodopa, Ropinirole, and Pramipexole.

Dosages

Based on the patients currently taking Carbidopa-Levodopa CR.

Top 10 (Show all)

All (Show top 10)

  0.5 25mg-100mg as needed 200mg as needed 2 25mg-100mg as needed 25 mg-100 mg all the time (24/7) 25mg-100mg as needed 25 mg-100 mg daily 25mg as needed 4 x 25 mg-100 mg all the time (24/7) 50mg-200mg as needed 5 25mg-100mg as needed daily 0.75 mg daily 3 daily 3 mg daily 3 other daily 4 mg daily 5 mg daily 6 other daily 10 mg daily 25 mg daily 50 mg daily 75 mg daily 80 mg daily 100 mg daily 10 mg-100 mg daily 25 mg-100 mg daily 50 mg-200 mg daily 111 mg daily 125 mg daily 1.25 x 25 mg-100 mg daily 135 mg daily 150 mg daily 1.5 x 25 mg-100 mg daily 200 mg daily 2 x 25 mg-100 mg daily 50 mg-200 mg daily 50 mg-200 mg one time 225 mg daily 250 mg daily 1.5 x 50 mg-200 mg daily 300 mg daily 3 x 25 mg-100 mg daily 2 x 50 mg-200 mg daily 400 mg daily 4 x 25 mg-100 mg daily 4.5 x 25 mg-100 mg daily 5 x 25 mg-100 mg daily 3 x 50 mg-200 mg daily 600 mg daily 6 x 25 mg-100 mg daily 700 mg daily 7 x 25 mg-100 mg daily 3 x 25 mg-250 mg daily 7.5 x 25 mg-100 mg daily 4 x 50 mg-200 mg daily 800 mg daily 8 x 25 mg-100 mg daily 1000 mg daily 10 x 25 mg-100 mg daily 5 x 50 mg-200 mg daily 1200 mg daily 6 x 50 mg-200 mg daily 5 x 25 mg-250 mg daily 1375 mg daily 9 x 50 mg-200 mg daily 100 x 25 mg-100 mg daily 50200 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 11 Number of Patients: 11 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 6 Number of Patients: 6 10 Number of Patients: 10 6 Number of Patients: 6 1 Number of Patients: 1 5 Number of Patients: 5 1 Number of Patients: 1 37 Number of Patients: 37 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 8 Number of Patients: 8 1 Number of Patients: 1 4 Number of Patients: 4 12 Number of Patients: 12 31 Number of Patients: 31 2 Number of Patients: 2 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 3 Number of Patients: 3 18 Number of Patients: 18 13 Number of Patients: 13 2 Number of Patients: 2 19 Number of Patients: 19 3 Number of Patients: 3 9 Number of Patients: 9 16 Number of Patients: 16 6 Number of Patients: 6 8 Number of Patients: 8 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 12 Number of Patients: 12 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 9 Number of Patients: 9 2 Number of Patients: 2 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Carbidopa-Levodopa CR or how long patients were taking Carbidopa-Levodopa CR before stopping.

Currently Taking Carbidopa-Levodopa CR

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
5
11
36
39
60

Stopped Taking Carbidopa-Levodopa CR

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
4
7
8
4
6
12
Why Patients Stopped Taking Carbidopa-Levodopa CR (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 22 51% Doctor's advice: 51%
Other 10 23% Other: 23%
Did not seem to work 9 21% Did not seem to work: 21%
Side effects too severe 8 19% Side effects too severe: 19%
Personal research 2 5% Personal research: 5%
Not indicated 2 5% Not indicated: 5%

Patient Reported Evaluations

Results from 47 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 61% 22
Moderate 19% 7
Slight 8% 3
None 6% 2
Can't tell 6% 2

Treat Parkinson's

Side-effects (as an overall problem)

Severe 13% 6
Moderate 19% 9
Mild 30% 14
None 38% 18

Top reported side-effects include: Vivid dreams, Fatigue, Back pain

Summary results are based on 47 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 47)

  • Marshview
    Sex: M
    Mouth/throat: mild
    Arms: mild
    Chest: mild
    Legs: mild
    See profile
  • Marshview
  • by Marshview
    Mar 31, 2008
  • EfficacyMajor
  • Side-effectsModerate
  • Treat Parkinson's
Advice/Tips
I was placed on this medicine to confirm my diagnosis of PD. I felt immediate results. However, the meds had to be taken at exactly the moment it was due. If I was just a bit late, I could tell the symptoms come back. It would be several hours before I returned to my former self.

  • jntdsn
    Sex: F
    Mouth/throat: mild
    Arms: moderate
    Chest: mild
    Legs: moderate
    See profile
  • jntdsn
  • by jntdsn
    Nov 18, 2004
  • EfficacyNone
  • Side-effectsSevere
  • Treat Parkinson's

See all evaluation results for Carbidopa-Levodopa CR

Report created on November 07, 2009.